PADI4 and neoplasm: The strategy of targeting CECN (chromatin extracellular chromatin networks) through PAD4 inhibition may restore the anti-tumorogenic functions of macrophages and improve CD8+ T cell infiltration in the tumor microenvironment, which is a promising direction for combination therapies with immunotherapy [115,129,130].